These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 20840172)

  • 1. The global diversion of pharmaceutical drugs
non-medical use and diversion of psychotropic prescription drugs in North America: a review of sourcing routes and control measures.
    Fischer B; Bibby M; Bouchard M
    Addiction; 2010 Dec; 105(12):2062-70. PubMed ID: 20840172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National drug control policy and prescription drug abuse: facts and fallacies.
    Manchikanti L
    Pain Physician; 2007 May; 10(3):399-424. PubMed ID: 17525776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fentanyl use among street drug users in Toronto, Canada: behavioural dynamics and public health implications.
    Firestone M; Goldman B; Fischer B
    Int J Drug Policy; 2009 Jan; 20(1):90-2. PubMed ID: 18508256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mental illness and psychotropic drug use among prescription drug overdose deaths: a medical examiner chart review.
    Toblin RL; Paulozzi LJ; Logan JE; Hall AJ; Kaplan JA
    J Clin Psychiatry; 2010 Apr; 71(4):491-6. PubMed ID: 20409446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug Policy and the Public Good: a summary of the book.
    Drugs and Public Policy Group
    Addiction; 2010 Jul; 105(7):1137-45. PubMed ID: 20642498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diversion and misuse of pharmaceutical stimulants: what do we know and why should we care?
    Kaye S; Darke S
    Addiction; 2012 Mar; 107(3):467-77. PubMed ID: 22313101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002.
    Gilson AM; Ryan KM; Joranson DE; Dahl JL
    J Pain Symptom Manage; 2004 Aug; 28(2):176-88. PubMed ID: 15276196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids.
    Manchikanti L; Singh A
    Pain Physician; 2008 Mar; 11(2 Suppl):S63-88. PubMed ID: 18443641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From balanced pain care to drug trafficking: the case of Dr. William Hurwitz and the DEA.
    Fishman SM
    Pain Med; 2005; 6(2):162-4. PubMed ID: 15773882
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective.
    Manchikanti L; Fellows B; Ailinani H; Pampati V
    Pain Physician; 2010; 13(5):401-35. PubMed ID: 20859312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription opioid related misuse, harms, diversion and interventions in Canada: a review.
    Fischer B; Argento E
    Pain Physician; 2012 Jul; 15(3 Suppl):ES191-203. PubMed ID: 22786457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Minnesota Prescription Monitoring Program.
    Herman C
    Northwest Dent; 2011; 90(2):33-5. PubMed ID: 21667591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid therapy and prescription drug diversion.
    Burgess FW; Pawasauskas J
    Med Health R I; 2008 Sep; 91(9):268-70. PubMed ID: 18834042
    [No Abstract]   [Full Text] [Related]  

  • 14. Diversion of prescription drugs to the black market: what the states are doing to curb the tide.
    Forgione DA; Neuenschwander P; Vermeer TE
    J Health Care Finance; 2001; 27(4):65-78. PubMed ID: 11434714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying controlled substance patterns of utilization requiring evaluation using administrative claims data.
    Parente ST; Kim SS; Finch MD; Schloff LA; Rector TS; Seifeldin R; Haddox JD
    Am J Manag Care; 2004 Nov; 10(11 Pt 1):783-90. PubMed ID: 15623267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pain medicine and drug law enforcement: an important step toward balance.
    Joranson DE; Portenoy RK
    J Pain Palliat Care Pharmacother; 2005; 19(1):3-5. PubMed ID: 15814508
    [No Abstract]   [Full Text] [Related]  

  • 17. The diversion of nonscheduled psychoactive prescription medications in the United States, 2002 to 2017.
    Kurtz SP; Buttram ME; Margolin ZR; Wogenstahl K
    Pharmacoepidemiol Drug Saf; 2019 May; 28(5):700-706. PubMed ID: 30909323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulating opioid prescribing through prescription monitoring programs: balancing drug diversion and treatment of pain.
    Fishman SM; Papazian JS; Gonzalez S; Riches PS; Gilson A
    Pain Med; 2004 Sep; 5(3):309-24. PubMed ID: 15367312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in and characteristics of admissions to treatment related to problematic prescription opioid use in Ontario, 2004-2009.
    Fischer B; Nakamura N; Rush B; Rehm J; Urbanoski K
    Drug Alcohol Depend; 2010 Jun; 109(1-3):257-60. PubMed ID: 20197216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Painkiller crackdown.
    Kalb C
    Newsweek; 2001 May; 137(20):38. PubMed ID: 11373803
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.